Cargando…
Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempol
BACKGROUND: Hyperhomocysteinemia (HHcy) and hyperglycemia cause diabetic cardiomyopathy by inducing oxidative stress and attenuating peroxisome proliferator- activated receptor (PPAR) gamma. However, their synergistic contribution is not clear. METHODS: Diabetic Akita (Ins2+/-) and hyperhomocysteine...
Autores principales: | Mishra, Paras K, Tyagi, Neetu, Sen, Utpal, Joshua, Irving G, Tyagi, Suresh C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2944245/ https://www.ncbi.nlm.nih.gov/pubmed/20828387 http://dx.doi.org/10.1186/1475-2840-9-49 |
Ejemplares similares
-
Homocysteine and Hypertension in Diabetes: Does PPARγ Have a Regulatory Role?
por: Sen, Utpal, et al.
Publicado: (2010) -
PPAR gamma agonist normalizes glomerular filtration rate, tissue levels of homocysteine, and attenuates endothelial-myocyte uncoupling in alloxan induced diabetic mice
por: Rodriguez, Walter E., et al.
Publicado: (2008) -
Hyperhomocysteinemia decreases bone blood flow
por: Tyagi, Neetu, et al.
Publicado: (2011) -
Mitochondrial mitophagy in mesenteric artery remodeling in hyperhomocysteinemia
por: Familtseva, Anastasia, et al.
Publicado: (2014) -
Blood flow interplays with elastin: collagen and MMP: TIMP ratios to maintain healthy vascular structure and function
por: Basu, Poulami, et al.
Publicado: (2010)